GLP-1s emerge as one of most ‘disruptive economic forces’ in healthcare
A panel examines the expansion of GLP-1 medications beyond weight loss, exploring new medical uses, potential side effects…
Cuba has plenty of doctors. So why is its healthcare system collapsing?
Since January, many Cubans have lived a life of near-constant darkness. The Trump administration’s oil blockades have led…
Docs removed two of my organs before figuring out what was wrong with me
A 35-year-old woman says doctors ignored her crippling pain for 15 years and removed two of her organs…
New WHO online course strengthens safe and sustainable health-care waste management
Safe management of health-care waste is essential to protect patients, health workers and communities, prevent pollution and support…
Whoop Expands Beyond Its Wearable Membership With Blood Tests
Health-tracking wearables offer insight into what’s going on inside our bodies, and it’s become increasingly common for those…
When an overloaded ED gets it wrong, who should be accountable?
At this time of year, crowded hospital emergency departments are a familiar sight around New Zealand. It’s also…
BioMarin to acquire Alesta Therapeutics for $275 million
Piotr Swat | Lightrocket | Getty Images CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose…
Safety and security of large language models in healthcare
Gommers, J. et al. Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without…
Wall Street analysts just called this healthcare stock a buy — here’s our take
Every weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET.…
Wall St rises as yields ease, Moderna lifts healthcare stocks
By Sinéad Carew and Avinash P Aug 19 (Reuters) – The main U.S. stock market indexes closed modestly…
CareCloud confirms 3.7M patients had their medical records stolen in data breach
Hackers have stolen the personal information and medical records of more than 3.75 million people in a data…
Moderna Rockets 93%, Merck Jumps 7% as Melanoma Therapy Meets Primary Goal in Phase 3 Trial
© hapabapa / iStock Editorial via Getty Images Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are rocketing…